Government of CanadaPublic Health Agency of Canada / Agence de santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Volume: 27S2 • July 2001

Construction-related Nosocomial Infections in Patients in Health Care Facilities
Decreasing the Risk of Aspergillus, Legionella and Other Infections

References

  1. Carter CD, Barr BA. Infection control issues in construction and renovation. Infect Control Hosp Epidemiol 1997;18(8):587-96.

  2. Parker J. Early engineering planning for health care facilities. Dimens Health Serv 1990;67(6):14-6.

  3. Gerson SL, Parker P, Jacobs MR et al. Aspergillosis due to carpet contamination. Infect Control Hosp Epidemiol 1994;15(4):221-23.

  4. Opal SM, Asp AA, Cannady PB et al. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 1986;153(3):634-37.

  5. Arnow PM, Andersen RL, Mainous PD et al. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978; 118:49-53.

  6. Patterson JE, Zidouh A, Miniter P et al. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997;18(2):104-8.

  7. Berg R. Nosocomial aspergillosis during hospital remodel. In: Soule BM, Larson EL, Preston GA, eds. Infections and nursing practice: prevention and control. St. Louis: Mosby, 1995:271-74.

  8. Iwen PC, Davis JC, Reed EC et al. Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol 1994;15(5):303-6.

  9. Lentino JR, Rosenkranz MA, Michaels JA et al. Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 1982;116(3):430-37.

  10. Flynn PM, Williams BG, Hetherington SV et al. Aspergillus terreus during hospital renovation. Infect Control Hosp Epidemiol 1993;14(7):363-65.

  11. Sarubbi FA, Kopf HB, Wilson MB et al. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982;125:33-8.

  12. Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect 1989;14:89-94.

  13. Loo VG, Bertrand C, Dixon C, et al. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 1996;17(6):360-64.

  14. Humphreys H, Johnson EM, Warnock DW et al. An outbreak of aspergillosis in a general ITU.
    J Hosp Infect 1991;18:167-77.

  15. Sessa A, Meroni M, Battini G et al. Nosocomial outbreak of Aspergillus fumigatus infection among patients in a renal unit? Nephrol Dial Transplant 1996;11:1322-24.

  16. Weems JJ, Davis BJ, Tablan OC et al. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control 1987;8(2):71-5.

  17. Lueg EA, Ballagh RH, Forte V. Analysis of the recent cluster of invasive fungal sinusitis at the Toronto Hospital for Sick Children. J Otolaryngol 1996;25(6):366-70.

  18. Aisner J, Schimpff SC, Bennett JE et al. Aspergillus infections in cancer patients: association with fireproofing materials in a new hospital. JAMA 1976;235(4):411-12.

  19. Klimowski LL, Rotstein C, Cummings KM. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. Infect Control Hosp Epidemiol 1989;10(7):299-305.

  20. Dewhurst AG, Cooper MJ, Khan SM et al. Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work. BMJ 1990;301:802-4.

  21. Krasinski K, Holzman RS, Hanna B et al. Nosocomial fungal infection during hospital renovation. Infect Control 1985;6(7):278-82.

  22. Collins PW, Kelsey SM, De Lord C et al. Invasive aspergillosis in immunosuppressed patients [letter]. BMJ 1990;301:1046-47.

  23. Weber SF, Peacock JE, Do K-A et al. Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. Infect Control Hosp Epidemiol 1990;11(5):235-42.

  24. Perraud M, Piens MA, Nicoloyannis N et al. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiol Infect 1987;99:407-12.

  25. Grossman ME, Fithian EC, Behrens C et al. Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol 1985;12(2, part 1):313-18.

  26.  American Health Consultants. Aspergillosis: a deadly dust may be in the wind during renovations. Hosp Infect Control 1995;22(10):125-26.

  27. Bryce EA, Walker M, Scharf S et al. An outbreak of cutaneous aspergillosis in a tertiary-care hospital. Infect Control Hosp Epidemiol 1996;17(3):170-72.

  28. Burpee RL. Medical malpractice; infection at surgery site - fungus. Massachusetts Lawyers Weekly 1999;27:2674.

  29. Shields ML, Joyner MV, Lee R. Invasive aspergillosis in immunosuppressed patients [letter]. BMJ 1990;301:1046-47.

  30. Haley CE, Cohen ML, Halter J et al. Nosocomial legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center. Ann Intern Med 1979;90:583-86.

  31. Shands KN, Ho JL, Meyer RD et al. Potable water as a source of legionnaires' disease. JAMA 1985;253(10):1412-16.

  32. Parry MF, Stampleman L, Hutchinson JH et al. Waterborne Legionella bozemanii and nosocomial pneumonia in immunosuppressed patients. Ann Intern Med 1985;103:205-10.

  33. Thacker SB, Bennett JV, Tsai TF et al. An outbreak in 1965 of severe respiratory illness caused by legionnaires' disease bacterium. J Infect Dis 1978;138(4):512-19.

  34. Mermel LA, Josephson SL, Giorgio CH et al. Association of legionnaires' disease with construction: contamination of potable water? Infect Control Hosp Epidemiol 1995;16(2):76-81.

  35. Bretagne S, Bart-Delabesse E, Wechsler J et al. Fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: nosocomial acquisition in a laminar-air flow room. J Hosp Infect 1997;36:235-39.

  36. Tablan OC, Anderson LJ, Arden NH et al. Guideline for prevention of nosocomial pneumonia. Part 1. Issues on prevention of nosocomial pneumonia - 1994. Am J Infect Control 1994;22:247-66.

  37. Overberger PA, Wadowsky RM, Schaper MM. Evaluation of airborne particulates and fungi during hospital renovation. Am Ind Hyg Assoc J 1995;56(7):706-12.

  38. Hughes WT, Flynn PM, Williams BG. Nosocomial infection in patients with neoplastic diseases. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins, 1996:618-631.

  39. Graybill JR. A history of the treatment of aspergillosis. In: Bossche HV, MacKenzie DWR, Cauwenbergh G, eds. Aspergillus and aspergillosis. New York: Plenum Press, 1988:229-42.

  40.  Lundstrom TS, Sobel JD. Fungal infections. In: Olmsted RN, ed. APIC infection control and applied epidemiology: principles and practice. St. Louis: Mosby, 1996:1-7.

  41. Pittet D, Huguenin T, Dharan S et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:541-44.

  42.  Alvarez M, Ponga BL, Rayon C et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995;33(12):3290-95.

  43. Grauhan O, Lohmann R, Lemmens P et al. Fungal infections in liver transplant recipients. Langenbecks Arch für Chirurgie 1994;379:372-75.

  44. Kirby BD, Snyder KM, Meyer RD et al. Legionnaires' disease: report of sixty-five nosocomially acquired cases and review of the literature. Medicine 1980;59(3):188-205.

  45. Edelstein PH. Control of legionella in hospitals. J Hosp Infect 1986;8:109-15.

  46. Kirby B, Harris A. Nosocomial legionnaires' disease. Semin Respir Infect 1987;2(4):255-61.

  47. Rhame FS. Nosocomial aspergillosis: how much protection for which patients? Infect Control Hosp Epidemiol 1989;10(7):296-98.

  48. Donelan S, Singh F, Provenzano A et al. Active and passive surveillance provide proof of the adequacy of air handling systems during hospital construction. Am J Infect Control 2000;28(1):85.

  49. Burmahl B. Hidden hazards - what you can't see can hurt you. Health Facil Manage 1999;19-26.

  50. Marston BJ, Lipman HB, Breiman RF. Surveillance for legionnaires' disease: risk factors for morbidity and mortality. Arch Intern Med 1994;154:2417-22.

  51. Burmahl B. Fungus fighters. Health Facil Manage 2000;15-20.

  52. Humphreys H. Infection control and the design of a new operating theatre suite. J Hospl Infect 1993;23:61-70.

  53. Kirkland T. Health care construction and indoor air quality. Can J Infect Control 1997;(Spring):17-9.

  54. Fallon RJ. How to prevent an outbreak of legionnaires' disease. J Hosp Infect 1994;27:247-56.

  55. Loeb M, Wilcox L, Thornley D et al. Bacillus species pseudobacteremia following hospital construction. Can J Infect Control 1995;10(2):37-40.

  56. Bartley JM and the 1997, 1998 and 1999 APIC Guidelines Committee. APIC state-of-the-art report: the role of infection control during construction in health care facilities. Am J Infect Control 2000;28(2):156-69.

  57. Sanchez RO, Hernandez JM. Infection control during construction and renovation in the operating room. Semin Perioper Nurs 1999;8(4):208-14.

  58. American Institute of Architects Academy of Architecture for Health. Guidelines for design and construction of hospital and health care facilities, 1996-97. Washington: American Institute of Architects Press, 1996.

  59. Boyd N, Mindorff C, Bruce D et al. Infection prevention during construction/renovation in hospitals: sample policies and bibliography. Sarnia, Ontario: St. Joseph's Health Centre, 1995.

  60. Brace SE. Infection control during construction: planning is key. Chicago, Illinois: American Society for Hospital Engineering of the American Hospital Association, 1993:1-13.

  61. Sahathevan M, Harvey FAH, Forbes G et al. Epidemiology, bacteriology and control of an outbreak of Nocardia asteroides infection on a liver unit. J Hosp Infect 1991;18(Supplement A):473-80.

  62. Goetz A, Yu VL. Copper-silver ionization: cautious optimism for Legionella disinfection and implications for environmental culturing. Am J Infect Control 1997;25(6):449-51.

  63. American Health Consultants. Construction breaches tied to bone marrow infections. Hosp Infect Control 1995;22(10):130-31.

  64. Hruszkewycz V, Ruben B, Hypes CM et al. A cluster of pseudofungemia associated with hospital renovation adjacent to the microbiology laboratory. Infect Control Hosp Epidemiol 1992;13(3):147-50.

  65. Jackson L, Klotz SA, Normand RE. A pseudoepidemic of Sporothrix cyanescens pneumonia occurring during renovation of a bronchoscopy suite. J Med Vet Mycol 1990;28:455-59.

  66. Hospital Infection Control. APIC coverage: dust from construction site carries pathogen into unit. Hosp Infect Control 1990;17(6):73.

  67. Loudon KW, Coke AP, Burnie JP et al. Invasive aspergillosis: clusters and sources. J Med Vet Mycol 1994;32:217-24.

  68. Rhame FS. Prevention of nosocomial aspergillosis. J Hosp Infect 1991;18(Supplement A):466-72.

  69. Rhame FS, Streifel AJ, Kersey JH et al. Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med 1984;(May 15):42-52.

  70. Walsh TJ, Dixon DM. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol 1989;5(2):131-42.

  71. Hay RJ. Pulmonary aspergillosis - the clinical spectrum. In: Bossche HV, MacKenzie DWR, Cauwenbergh G, eds. Aspergillus and aspergillosis. New York: Plenum Press, 1988:97-105.

  72. Decker MD, Schaffner W. Nosocomial diseases of health care workers spread by the airborne or contact routes (other than tuberculosis). In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins, 1996:874.

  73. Bocquet P, Brucker G. Integrated struggle against aspergillosis at the level of a single hospital or a hospital cluster - Lutte integrée contre l'aspergillose au niveau d'un hôpital ou d'un groupement hospitalier (abstract). Pathologie Biologie 1994;42(7):730-36.

  74. Hay RJ. The prevention of invasive aspergillosis - a realistic goal? J Antimicrob Chemother 1993;32:515-17.

  75. Drusin LM, Bancroft EA, Mintz J et al. An unusual cluster of fungal colonization and infections associated with hospital renovation. Am J Infect Control 2000;28(1):81.

  76. Parker J. A general proposition on the legionella-scalding dilemma. Health Estate J 1992;46:15-16, 18.

  77. Doebbeling BN, Wenzel RP. The epidemiology of Legionella pneumophila infections. Semin Respir Infect 1987;2(4):206-21.

  78. Alary M, Joly JR. Factors contributing to the contamination of hospital water distribution systems by legionellae. J Infect Dis 1992;165:565-69.

  79. Stout JE, Yu VL, Best MG. Ecology of Legionella pneumophila within water distribution systems. Appl Environ Microbiol 1985;49(1):221-28.

  80. Feeley JC. Legionellosis: risk associated with building design. In: Kundsin RB, ed. Architectural design and indoor microbial pollution. New York: Oxford University Press, 1988:218-27.

  81. Goetz A, Yu VL. Nosocomial legionella infection. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins, 1996:388-99.

  82. Goetz AM, Yu VL. Legionella species. In: Olmsted RN, ed. APIC infection control and applied epidemiology: principles and practice. St. Louis: Mosby, 1996:1-4.

  83. Freije MR. Legionellae control in health care facilities: a guide for minimizing risk. Indianapolis, IN: HC Information Resources. Inc., 1996.

  84. Fliermans CB. Legionella ecology. In: Burge HA, ed. Boca Raton: Lewis Publishers, 1995:49-76.

  85. Korvick JA, Yu VL, Fang G. Legionella species as hospital-acquired respiratory pathogens. Semin Respir Infect 1987;2(1):34-47.

  86. Arnow PM, Sadigh M, Costas C et al. Endemic and epidemic aspergillosis associated with in-hospital replication of aspergillus organisms. J Infect Dis 1991;164(November):998-1002.

  87. Rotstein C, Cummings KM, Tidings J et al. An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study. Infect Control 1985;6(9):347-55.

  88. Sherertz RJ, Belani A, Kramer BS et al. Impact of air filtration on nosocomial aspergillus infections: unique risk of bone marrow transplant recipients. Am J Med 1987;83:709-18.

  89. Working Party of the British Society for Antimicrobial Chemotherapy. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J Antimicrob Chemother 1993;32:5-21.

  90. Fenelon LE. Protective isolation: who needs it? J Hosp Infect 1995;30:218-22.

  91. Benenson AS. Legionellosis. In: Benenson AS, ed. Control of communicable diseases manual. Washington, DC: American Health Association, 1995:256-58.

  92. Vesley D, Streifel AJ. Environmental services. In: Mayhall CG, ed. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wlkins, 1999:1047-53.

  93. Perl TM, Chotani R, Agawala R. Infection control and prevention in bone marrow transplant patients. In: Mayhall CG, ed. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins, 1999:803-44.

  94. Lawson CN. Commissioning hospitals for compliance. ASHRAE Transactions: Symposia 1993;99:1183-90.

  95. American Health Consultants. Reduce dust and danger during construction. Hosp Infect Control 1997;24(2):26-9.

  96. Streifel AJ, Lauer JL, Vesley D et al. Aspergillus fumigatus and other thermotolerant fungi generated by hospital building demolition. Appl Environ Microbiol 1983;46(2):375-78.

  97. Rautiala S, Reponen T, Nevalainen A et al. Control of exposure to airborne viable microorganisms during remediation of moldy buildings: report of three case studies. Am Ind Hyg Assoc J 1998;59:455-60.

  98. Kundsin RB. The microbiologist's role in evaluating the hygienic environment. In: Kundsin RB, ed. Architectural design and indoor microbial pollution. New York: Oxford University Press, 1988:103-22.

  99. Canadian Standards Association. Special requirements for plumbing installations in health care facilities (Z317.1-98). Etobicoke: Canadian Standards Association, 1998.

  100. American Health Consultants. Are patients at risk from the hospital environment? Hosp Infect Control 1999;26(12):164-66.

  101. Streifel AJ. Maintenance and engineering; biomedical engineering. In: Olmsted RN, ed. Infection control and applied epidemiology principles and practice. St. Louis: Mosby, 1996:1-7.

  102. Williams PL. Fungus among us - fighting fungal infection during construction. Health Facil Manage 2000;13(3):39-44.

  103. Stout JE, Yu VL. Nosocomial Legionella infection. In: Mayhall CG, ed. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins, 1999:453-65.

  104. Streifel AJ. Aspergillosis and construction. In: Kundsin RB, ed. Architectural design and indoor microbial pollution. New York: Oxford University Press, 1988:198-217.

  105.  Woods JE, Arora S. Indoor air quality: engineering considerations. Immunol Allergy Clin North Am 1994;14(3):495-519.

  106. Luoma M, Pasanen AL, Pasanen P et al. Duct cleaning - a literature survey. Air Infiltration Rev 1993;14:1-5.

  107. Centers for Disease Control and Prevention. Guideline for prevention of nosocomial pneumonia. In: Friede A, O'Carroll PW, Nicola RM et al, eds. CDC prevention guidelines: a guide to action. Atlanta, Georgia: Williams & Wilkins, 1997:1277-354.

  108. Raad II, Osting C, Hanna H et al. Masking of neutropenic patients upon transport from patient rooms is associated with decrease in nosocomial aspergillosis during construction. Am J Infect Control 2000;28(1):82.

  109. Kennedy HF, Michie JR, Richardson MD. Air sampling for Aspergillus spp. during building activity in a paediatric hospital ward. J Hosp Infect 1995;31:322-25.

  110. Hermans RD, Streifel AJ. Ventilation designs. Proceedings of the Workshop on Engineering Controls for Preventing Airborne Infections in Workers in Health Care and Related Facilities. Cincinnati, OH: NIOSH, 1994:107-46.

  111. Ontario Ministry of Health. Capital planning manual: a guide to the capital planning process. Toronto, ON: Queen's Printer for Ontario, 1996.

  112. Nova Scotia Department of Health. Health care capital construction guidelines. Halifax, NS: Nova Scotia Department of Health, 1998.

  113. Saskatchewan Health. Planning guide for Saskatchewan health districts part III: facilities planning. Regina, SK: Capital and Special Operating Policy Unit, Saskatchewan Health (currently under revision).

  114. Yukon Government Services. Building development projects procedures manual. Whitehorse, Yukon: Yukon Health and Social Services, 1992.

  115. Post NM. Buildings that stink - the tyranny of toxic mold. Engineering News Record 1999;242(17):32-40.

  116. Hockaday PS. The architect's concern about indoor pollution. In: Kundsin RB, ed. Architectural design and indoor microbial pollution. New York: Oxford University Press, 1988:31-9.

[Previous] [Table of Contents] [Next]

 
Last Updated: 2001-08-15 Top
Important Notices